4//SEC Filing
Maynard Ryan D 4
Accession 0001104659-24-119195
CIK 0001425205other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:00 PM ET
Size
9.7 KB
Accession
0001104659-24-119195
Insider Transaction Report
Form 4
Maynard Ryan D
Director
Transactions
- Exercise/Conversion
Common Stock
2024-11-12$7.45/sh+50,000$372,500→ 57,500 total - Sale
Common Stock
2024-11-12$10.06/sh−50,000$503,000→ 7,500 total - Exercise/Conversion
Stock Option (right to buy)
2024-11-12−50,000→ 0 totalExercise: $7.45From: 2016-02-16Exp: 2025-02-15→ Common Stock (50,000 underlying)
Footnotes (5)
- [F1]Represents an exercise of stock options prior to the 10-year expiration date of such options.
- [F2]Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $10.05 and $10.105.
- [F4]These options became exercisable in four equal quarterly installments of 12,500 each following the date of grant, which was February 16, 2015.
- [F5]Such aggregate number reflects the remainder of such stock options granted on February 16, 2015, but does not include any other stock options held by such Reporting Person.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001363984
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 5:00 PM ET
- Size
- 9.7 KB